Introduction: We see increased use of existing observational data in order to achieve fast and transparent production of empirical evidence in health care research. Multiple databases are often used to increase power, to assess rare exposures or outcomes, or to study diverse populations. For privacy and sociological reasons, original data on individual subjects can\u2019t be shared, requiring a distributed network approach where data processing is performed prior to data sharing. Case Descriptions and Variation Among Sites: We created a conceptual framework distinguishing three steps in local data processing: (1) data reorganization into a data structure common across the network; (2) derivation of study variables not present in original d...
Purpose In this proof-of-concept paper we describe the framework, process, and preliminary results o...
Several pharmacoepidemiology networks have been developed over the past decade that use a distribute...
Abstract Introduction Safety issue of the new non-vitamin K Target Specific Oral Anticoagulant...
Introduction: We see increased use of existing observational data in order to achieve fast and trans...
Over the past decade, characterizing the safety and effectiveness of drugs has advanced through dist...
Computerized health care databases have been widely described as an excellent opportunity for resear...
Computerized health care databases have been widely described as an excellent opportunity for resear...
Background The Observational Medical Outcomes Partnership (OMOP) has just completed a large scale em...
Background The Observational Medical Outcomes Partnership (OMOP) has just completed a large scale em...
Background: EU-ADR is a European research project resulting in a computerized system exploiting data...
Background: Research networks offer multidisciplinary expertise and promote information exchange be...
The EU-ADR project aims to exploit different European electronic healthcare records (EHR) databases ...
Computerized health care databases have been widely described as an excellent opportunity for resear...
There is growing interest in using observational data to assess the safety, effectiveness, and cost ...
Introduction Several large health data networks such as FDA Sentinel, PCORnet, and the Canadian Netw...
Purpose In this proof-of-concept paper we describe the framework, process, and preliminary results o...
Several pharmacoepidemiology networks have been developed over the past decade that use a distribute...
Abstract Introduction Safety issue of the new non-vitamin K Target Specific Oral Anticoagulant...
Introduction: We see increased use of existing observational data in order to achieve fast and trans...
Over the past decade, characterizing the safety and effectiveness of drugs has advanced through dist...
Computerized health care databases have been widely described as an excellent opportunity for resear...
Computerized health care databases have been widely described as an excellent opportunity for resear...
Background The Observational Medical Outcomes Partnership (OMOP) has just completed a large scale em...
Background The Observational Medical Outcomes Partnership (OMOP) has just completed a large scale em...
Background: EU-ADR is a European research project resulting in a computerized system exploiting data...
Background: Research networks offer multidisciplinary expertise and promote information exchange be...
The EU-ADR project aims to exploit different European electronic healthcare records (EHR) databases ...
Computerized health care databases have been widely described as an excellent opportunity for resear...
There is growing interest in using observational data to assess the safety, effectiveness, and cost ...
Introduction Several large health data networks such as FDA Sentinel, PCORnet, and the Canadian Netw...
Purpose In this proof-of-concept paper we describe the framework, process, and preliminary results o...
Several pharmacoepidemiology networks have been developed over the past decade that use a distribute...
Abstract Introduction Safety issue of the new non-vitamin K Target Specific Oral Anticoagulant...